Market Currents
Amgen (AMGN) CEO Kevin Sharer will retire in May and be replaced by company President and COO...
-
Friday, December 16, 2011, 4:52 AM ETAmgen (AMGN) CEO Kevin Sharer will retire in May and be replaced by company President and COO Robert Bradway. RBC Capital analyst Michael Yee says the biotech's new CEO will need to "reinvigorate a focus of innovation for new products and a focus on cutting expenses." Are both those possible? (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment:
pressers work cheaper than phd's. theft has always been an innovative and cost effective way of finding new products.
ha!